Back to Results
First PageMeta Content
Oncology / Chemotherapy-induced nausea and vomiting / Drug discovery / Organochlorides / Prodrugs / 5-HT3 antagonist / Cyclophosphamide / Chemotherapy / Vomiting / Medicine / Chemistry / Antiemetics


P11444 - ASCO2014 MEC and HEC
Add to Reading List

Document Date: 2014-05-30 11:29:54

Open Document

File Size: 273,37 KB

Share Result on Facebook

City

Memphis / Portland / Tucson / Overall / Boston / Chicago / Waltham / /

Company

3TESARO Inc. / US Oncology / AEs / Subjects / /

Continent

America / /

Country

United States / /

Event

FDA Phase / /

Facility

Clinical Research Center / Tufts Medical Center / Tennessee Health Sciences Center / /

IndustryTerm

control groups / rolapitant / control / prevention of CINV in cancer / /

MedicalCondition

tumor / cancer / Chemotherapy-Induced Nausea / nausea/vomiting / nausea / Vomiting / vomiting domain / Breast cancer / significant nausea / /

MedicalTreatment

Chemotherapy / /

Organization

Medical Center / 2Arizona Clinical Research Center / Tennessee Health Sciences Center / /

Product

granisetron / Carboplatin / dexamethasone / cytarabine / cyclophosphamide / ifosfamide / Rescue Medication / rolapitant / /

ProvinceOrState

Tennessee / Illinois / Oregon / Arizona / Massachusetts / /

Region

South Africa / /

Technology

Chemotherapy / /

SocialTag